What is IQVIA Holdings Inc. share price today?

IQVIA Holdings Inc. (IQV) share price today is {{live_price}}.

Can Indians buy IQVIA Holdings Inc. shares?

Yes, Indians can invest in the IQVIA Holdings Inc. (IQV) from India. With INDmoney, you can buy IQVIA Holdings Inc. at 0 brokerage. The step-by-step process is as follows: Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes) Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates. Once funds are transferred successfully, you can buy IQVIA Holdings Inc. at zero transaction cost.

How can I buy IQVIA Holdings Inc. shares from India?

It is very easy to buy IQVIA Holdings Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of IQVIA Holdings Inc. be purchased?

Yes, you can buy fractional shares of IQVIA Holdings Inc. with INDmoney app.

What are the documents required to start investing in IQVIA Holdings Inc. stocks?

To start investing in IQVIA Holdings Inc., You will need the following documents: Proof of Identification (PAN, Aadhaar etc) Proof of address (Aadhaar, Voter ID etc) These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of IQVIA Holdings Inc.

Today’s highest price of IQVIA Holdings Inc. (IQV) is {{1_rba_end}}. Today’s lowest price of IQVIA Holdings Inc. (IQV) is {{1_rba_st}}.

What is today's market capitalisation of IQVIA Holdings Inc.

Today's market capitalisation of IQVIA Holdings Inc. IQV is 37.0B

What is the 52 Week High and Low Range of IQVIA Holdings Inc.

52 Week High {{rba_end}} 52 Week Low {{rba_st}}

How much percentage IQVIA Holdings Inc. is down from its 52 Week High?

IQVIA Holdings Inc. (IQV) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

How much percentage IQVIA Holdings Inc. is up from its 52 Week low?

IQVIA Holdings Inc. (IQV) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

What are the historical returns of IQVIA Holdings Inc.?

1 Month Returns {{1mr}}% 3 Months Returns {{3mr}}% 1 Year Returns {{1yr}}% 5 Years Returns {{5yr}}%

Who is the Chief Executive Officer (CEO) of IQVIA Holdings Inc.

Mr. Ari Bousbib is the current Chief Executive Officer (CEO) of IQVIA Holdings Inc..

Home

US Stocks

IQVIA Holdings Inc.

IQVIA Holdings Inc. (IQV)

$198.96

-0.49

(-0.25%)▲

Live

Insights on IQVIA Holdings Inc.

Decreasing Revenue
Revenue is down for the last 2 quarters, 3.73B → 3.65B (in $), with an average decrease of 2.3% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, 227.0M → 291.0M (in $), with an average increase of 22.0% per quarter
Vs IDXX
In the last 1 year, Idexx Laboratories, Inc. has given 17.6% return, outperforming this stock by 27.1%
Vs IDXX
In the last 3 years, Idexx Laboratories, Inc. has given 51.8% return, outperforming this stock by 18.4%

Performance

$198.44
$202.38
$198.96
0.26%
Downside
Day's Volatility :1.95%
Upside
1.69%
$165.75
$249.11
$198.96
16.69%
Downside
52 Weeks Volatility :33.46%
Upside
20.13%

Returns

Period	IQVIA Holdings Inc.	Sector (Health Care)	S&P500
3 Months	-4.33%	0.3%	5.9%
6 Months	-8.52%	-8.3%	3.1%
1 Year	-7.34%	-4.8%	1.1%
3 Years	33.49%	23.8%	38.1%

Highlights

Market Capitalization	37.0B
Book Value	$31.98
Dividend Share	0.0
Dividend Yield	0.0%
Earnings Per Share (EPS)	5.6
PE Ratio	35.62
PEG Ratio	1.48
Wall Street Target Price	243.71

Profit Margin	7.28%
Operating Margin TTM	12.74%

Return On Assets TTM	4.55%
Return On Equity TTM	17.8%

Revenue TTM	14.5B
Revenue Per Share TTM	77.69
Quarterly Revenue Growth YOY	2.4%
Gross Profit TTM	5.0B
EBITDA	2.6B
Diluted Eps TTM	5.6
Quarterly Earnings Growth YOY	-0.09

EPS Estimate Current Year	10.42
EPS Estimate Next Year	11.96
EPS Estimate Current Quarter	16.69
EPS Estimate Next Quarter	17.09

Analyst Recommendation

Buy

89%Buy

10%Hold

0%Sell

Based on 28 Wall street analysts offering stock ratings for IQVIA Holdings Inc.(by analysts ranked 0 to 5 stars)

Based on 28 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast

What analysts predicted

Upside of 22.49%

Current $198.96

Target $243.71

Company Financials

	FY17	Y/Y Change
Revenue	9.7B	↑ 41.6%
Net Income	1.3B	↑ 1038.26%
Net Profit Margin	13.44%	↑ 11.77%

	FY18	Y/Y Change
Revenue	10.4B	↑ 6.91%
Net Income	259.0M	↓ 80.21%
Net Profit Margin	2.49%	↓ 10.95%

	FY19	Y/Y Change
Revenue	11.1B	↑ 6.49%
Net Income	191.0M	↓ 26.25%
Net Profit Margin	1.72%	↓ 0.77%

	FY20	Y/Y Change
Revenue	11.4B	↑ 2.44%
Net Income	279.0M	↑ 46.07%
Net Profit Margin	2.46%	↑ 0.74%

	FY21	Y/Y Change
Revenue	13.9B	↑ 22.14%
Net Income	966.0M	↑ 246.24%
Net Profit Margin	6.96%	↑ 4.5%

	FY22	Y/Y Change
Revenue	14.4B	↑ 3.86%
Net Income	1.1B	↑ 12.94%
Net Profit Margin	7.57%	↑ 0.61%

	Q4 FY21	Q/Q Change
Revenue	3.6B	↑ 7.23%
Net Income	318.0M	↑ 21.84%
Net Profit Margin	8.75%	↑ 1.05%

	Q1 FY22	Q/Q Change
Revenue	3.6B	↓ 1.87%
Net Income	325.0M	↑ 2.2%
Net Profit Margin	9.11%	↑ 0.36%

	Q2 FY22	Q/Q Change
Revenue	3.5B	↓ 0.76%
Net Income	256.0M	↓ 21.23%
Net Profit Margin	7.23%	↓ 1.88%

	Q3 FY22	Q/Q Change
Revenue	3.6B	↑ 0.59%
Net Income	283.0M	↑ 10.55%
Net Profit Margin	7.94%	↑ 0.71%

	Q4 FY22	Q/Q Change
Revenue	3.7B	↑ 4.97%
Net Income	227.0M	↓ 19.79%
Net Profit Margin	6.07%	↓ 1.87%

	Q1 FY23	Q/Q Change
Revenue	3.7B	↓ 2.33%
Net Income	291.0M	↑ 28.19%
Net Profit Margin	7.97%	↑ 1.9%

	FY17	Y/Y Change
Total Assets	22.7B	↑ 7.23%
Total Liabilities	14.4B	↑ 16.49%

	FY18	Y/Y Change
Total Assets	22.5B	↓ 0.85%
Total Liabilities	15.6B	↑ 8.42%

	FY19	Y/Y Change
Total Assets	23.3B	↑ 3.11%
Total Liabilities	17.0B	↑ 8.93%

	FY20	Y/Y Change
Total Assets	24.6B	↑ 5.65%
Total Liabilities	18.3B	↑ 7.63%

	FY21	Y/Y Change
Total Assets	24.7B	↑ 0.51%
Total Liabilities	18.6B	↑ 1.99%

	FY22	Y/Y Change
Total Assets	25.3B	↑ 2.62%
Total Liabilities	19.6B	↑ 4.96%

	Q4 FY21	Q/Q Change
Total Assets	24.7B	↑ 2.73%
Total Liabilities	18.6B	↑ 2.43%

	Q1 FY22	Q/Q Change
Total Assets	25.0B	↑ 1.13%
Total Liabilities	19.1B	↑ 2.16%

	Q2 FY22	Q/Q Change
Total Assets	24.4B	↓ 2.23%
Total Liabilities	19.1B	↑ 0.06%

	Q3 FY22	Q/Q Change
Total Assets	24.2B	↓ 0.78%
Total Liabilities	18.9B	↓ 0.97%

	Q4 FY22	Q/Q Change
Total Assets	25.3B	↑ 4.6%
Total Liabilities	19.6B	↑ 3.69%

	Q1 FY23	Q/Q Change
Total Assets	25.7B	↑ 1.59%
Total Liabilities	19.8B	↑ 1.2%

	FY17	Y/Y Change
Operating Cash Flow	970.0M	↑ 12.79%
Investing Cash Flow	-1.2B	↓ 168.75%
Financing Cash Flow	-72.0M	↓ 96.85%

	FY18	Y/Y Change
Operating Cash Flow	1.3B	↑ 29.28%
Investing Cash Flow	-810.0M	↓ 31.93%
Financing Cash Flow	-452.0M	↑ 527.78%

	FY19	Y/Y Change
Operating Cash Flow	1.4B	↑ 13.0%
Investing Cash Flow	-1.2B	↑ 46.91%
Financing Cash Flow	-276.0M	↓ 38.94%

	FY20	Y/Y Change
Operating Cash Flow	2.0B	↑ 38.25%
Investing Cash Flow	-796.0M	↓ 33.11%
Financing Cash Flow	-217.0M	↓ 21.38%

	FY21	Y/Y Change
Operating Cash Flow	2.9B	↑ 50.18%
Investing Cash Flow	-2.1B	↑ 164.2%
Financing Cash Flow	-1.2B	↑ 469.12%

	FY22	Y/Y Change
Operating Cash Flow	2.3B	↓ 23.18%
Investing Cash Flow	-2.0B	↓ 4.61%
Financing Cash Flow	-329.0M	↓ 73.36%

	Q4 FY21	Q/Q Change
Operating Cash Flow	692.0M	↓ 18.01%
Investing Cash Flow	-647.0M	↓ 40.91%
Financing Cash Flow	-138.0M	↑ 109.09%

	Q1 FY22	Q/Q Change
Operating Cash Flow	508.0M	↓ 26.59%
Investing Cash Flow	-613.0M	↓ 5.26%
Financing Cash Flow	144.0M	↓ 204.35%

	Q2 FY22	Q/Q Change
Operating Cash Flow	329.0M	↓ 35.24%
Investing Cash Flow	-199.0M	↓ 67.54%
Financing Cash Flow	-29.0M	↓ 120.14%

	Q3 FY22	Q/Q Change
Operating Cash Flow	863.0M	↑ 162.31%
Investing Cash Flow	-717.0M	↑ 260.3%
Financing Cash Flow	-251.0M	↑ 765.52%

	Q4 FY22	Q/Q Change
Operating Cash Flow	2.3B	↑ 161.88%
Investing Cash Flow	-2.0B	↑ 179.78%
Financing Cash Flow	-329.0M	↑ 31.08%

	Q1 FY23	Q/Q Change
Operating Cash Flow	417.0M	↓ 81.55%
Investing Cash Flow	-222.0M	↓ 88.93%
Financing Cash Flow	87.0M	↓ 126.44%

Technicals Summary

Sell

Neutral

Buy

IQVIA Holdings Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
IQVIA Holdings Inc.	4.97%	-8.52%	-7.34%	33.49%	98.5%
IDEXX Laboratories, Inc.	-4.22%	10.11%	19.74%	50.21%	124.29%
Agilent Technologies Inc.	-11.51%	-22.3%	-5.6%	33.93%	92.09%
Thermo Fisher Scientific, Inc.	-4.83%	-6.82%	-8.03%	49.43%	147.46%
Danaher Corp.	-3.94%	-15.07%	-11.98%	40.41%	129.34%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
IQVIA Holdings Inc.	35.62	35.62	1.48	10.42	0.18	0.05	0.0	31.98
IDEXX Laboratories, Inc.	55.23	55.23	7.21	9.69	0.94	0.22	0.0	10.13
Agilent Technologies Inc.	26.91	26.91	2.36	5.63	0.25	0.1	0.01	18.96
Thermo Fisher Scientific, Inc.	34.01	34.01	4.28	23.68	0.14	0.05	0.0	109.55
Danaher Corp.	25.0	25.0	3.24	8.74	0.14	0.06	0.0	68.31

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
IQVIA Holdings Inc.	Buy	$37.0B	98.5%	35.62	7.28%
IDEXX Laboratories, Inc.	Buy	$38.9B	124.29%	55.23	20.38%
Agilent Technologies Inc.	Buy	$35.3B	92.09%	26.91	19.09%
Thermo Fisher Scientific, Inc.	Buy	$201.4B	147.46%	34.01	13.75%
Danaher Corp.	Buy	$171.3B	129.34%	25.0	22.4%

Institutional Holdings

Vanguard Group Inc
11.65%
BlackRock Inc
8.50%
State Street Corporation
4.44%
AllianceBernstein L.P.
2.69%
FMR Inc
2.43%
Morgan Stanley - Brokerage Accounts
2.06%

Organization	IQVIA Holdings Inc.
Employees	87000
CEO	Mr. Ari Bousbib
Industry	Health Services

IQVIA Holdings Inc. (IQV)

Insights on IQVIA Holdings Inc.

Decreasing Revenue

Increasing Net Profit

Vs IDXX